ArticleNEJM catalyst innovations in care delivery2026
The Increasing Community Access to Testing, Treatment, and Response Program - A Model for Future Public Health Emergency Response.
Article in NEJM catalyst innovations in care delivery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Characteristics Influencing Adherence to SARS-CoV-2 Serial Antigen Testing Following a Federal Safety Communication: Cohort Study.JMIR public health and surveillance · 2026Article
- Evaluation of self-collection of nasal swab specimens for COVID-19 diagnostic testing in children in the United States, 2020-2023.Journal of clinical microbiology · 2026Article
- Comparative evaluation of SARS-CoV-2 laboratory testing data sources for U.S. COVID-19 public health surveillance, 2020-2024.Frontiers in public health · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Rapid distribution of diagnostic testing and countermeasures in community settings is a persistent challenge during pandemics. During the coronavirus disease 2019 (Covid-19) public health emergency, the Increasing Community Access to Testing, Treatment, and Response program at the U.S. Centers for Disease Control and Prevention provided free Covid-19 testing through retail pharmacies. The program enabled timely diagnosis for uninsured individuals and maintained a robust pharmacy network with the capacity to serve the entire U.S. population. This public-private partnership model can be employed for future public health emergency response, surveillance, research, and prevention.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.